FDA Warns Pfizer Inc.'s Drug Tygacil Raises Risk of Death
Published: Sep 30, 2013
Pfizer Inc's antibacterial drug Tygacil increases the risk of death whether used as authorized by the U.S. Food and Drug Administration or for unapproved conditions, the agency warned on Friday. Pfizer must place a warning inside a black box on the drug's label, indicating the risk is of the most serious nature. The FDA said the drug, which is usually given intravenously, should only be used when alternative treatments are not suitable.
Help employers find you! Check out all the jobs and post your resume.